Overview

Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections

Status:
Completed

Trial end date:
2009-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether NXL104 plus ceftazidime is effective in the treatment of complicated intra-abdominal infections as compared to a comparator group.

Phase:

Phase 2

Details

Lead Sponsor:

Novexel Inc
Pfizer

Treatments:

Avibactam
Ceftazidime
Meropenem
Metronidazole
Thienamycins